原酶功能化的脂质体在胰腺癌中克服了流体障碍
Jee-Eun Hwang1,2,3, Miyeon Jeon4, Hyunjoon Yim4
1Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, Seoul National University, Seoul 08826, Republic of Korea.
ACS nano
|February 18, 2026
概括
与原酶 (GLCLs) 结合的含有格姆西塔的脂质体破坏了胰腺癌中的纤维化屏障. 这增强了药物透,并显著抑制了瘤的生长,提供了一个新的治疗策略.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 胰腺管道腺癌 (PDAC) 的特点是密集的,富含原蛋白的肌层阻碍药物输送,限制治疗疗效.
- PDAC中的纤维细胞外基质 (ECM) 形成了一个物理屏障,减少了血管 perfusion 和化学疗法药物的透,如gemcitabine.
研究的目的:
- 开发和评估gemcitabine装载的原酶结合脂质体 (GLCLs),用于增强PDAC中的药物输送.
- 调查GLCLs在酶上重塑原ECM的能力,并改善内药物透.
主要方法:
- 合成和描述GLCLs,评估酶活性,稳定性和药理动力学特征.
- 在带有PDAC的小鼠模型中评估GLCLs,使用体内成像,体外光和定量溶解喷射电离化质谱成像 (DESI-MSI).
- 通过GLCLs抑制瘤生长的比较与非功能化脂质体 (GLL) 和自由凝胺.
主要成果:
- 与GLL相比,GLCL显示保持了原酶活性,延长了血液循环,以及较高的瘤积累.
- GLCLs实现了更深,更均的内凝丁透.
- 在同等剂量下,GLCLs的瘤生长抑制率 (69.8%) 比GLL (10.9%) 高出6倍.
结论:
- 通过酶性ECM重塑,GLCLs有效地克服了PDAC中的纤维原障碍.
- 这种以纳米载体为媒介的药物输送策略使药物能够深入内透,为PDAC治疗提供了一种有前途和临床可转换的方法.
- 该研究提供了使用多尺度成像方法在PDAC中纳米载体介导药物透的分子水平验证.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...